UNSPSC 41202043: Norovirus serological reagents

In this classification, Norovirus serological reagents are devices used in test to identify specific Norovirus antibodies in serum. US FDA regulates Norovirus serological reagents under 21 CFR 866.3395 and under FDA product code OUC.

UNSPSC 41202043 Norovirus serological reagents is a Commodity code that identifies infectious-disease screening reagents and test kits purchased by state and local public health departments, corrections agencies, and clinical laboratories. State and local governments buy under this code when procuring serological reagents, test kits, calibrators, control materials, and related consumables for rapid or automated diagnostic testing of infectious agents. The recent opportunities show a mixed picture: most solicitations tagged with this code actually purchase HIV, Syphilis, and Hepatitis test kits and screening assays rather than norovirus-specific reagents. The issuing bodies include state public health departments (Illinois Department of Public Health), county corrections agencies (Collin County Community Supervision and Corrections Department, Texas), municipal health programs (City of Austin), state criminal justice agencies (Texas Department of Criminal Justice), and university health centers (University of Houston). Illinois Department of Public Health appears repeatedly across multiple recent procurements, reflecting ongoing demand for HIV and Syphilis testing infrastructure at state laboratories.

Geographic concentration centers on Texas and Illinois, with secondary activity in Florida. Representative recent opportunities include the Illinois Department of Public Health's five-year Invitation for Bid (posted February 13, 2026, due March 16, 2026) for automated Hepatitis B/C, HIV-1/HIV-2, and Syphilis screening assays and instrumentation for Jackson County, with estimated annual volumes of 13,200 HIV tests and 11,000 Syphilis tests; Collin County Community Supervision and Corrections Department's Request for Proposal (posted July 9, 2026, due July 23, 2026) for offender specimen collection and drug testing services with approximately 25,031 annual tests at an estimated contract value of $600,000 over two years with three optional renewals; and the City of Austin's Invitation for Bid (posted June 15, 2026, due July 17, 2026) for rapid HIV test kits and controls to support the Austin Public Health Program. Illinois also conducted emergency sole-source procurements with Abbott Laboratories for HIV and Syphilis reagents and related supplies supporting CLIA-certified laboratory operations, indicating critical reliance on established vendor relationships and proprietary equipment ecosystems for public health testing continuity.